Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02999958Completed
Randomised, double-blind trial (2 arms), sponsored by Vitrolife. Primary endpoint: Percentage of good quality blastocysts per fertilized oocyte at Day 5. Started Dec 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02999958.